Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal Cancer

Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):977-993. doi: 10.1016/j.ijrobp.2019.08.020. Epub 2019 Aug 22.

Abstract

The goal of treatment for early stage rectal cancer is to optimize oncologic outcome while minimizing effect of treatment on quality of life. The standard of care treatment for most early rectal cancers is radical surgery alone. Given the morbidity associated with radical surgery, local excision for early rectal cancers has been explored as an alternative approach associated with lower rates of morbidity. The American Radium Society Appropriate Use Criteria presented in this manuscript are evidence-based guidelines for the use of local excision in early stage rectal cancer that include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) used by a multidisciplinary expert panel to rate the appropriateness of imaging and treatment procedures. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. These guidelines are intended for the use of all practitioners and patients who desire information regarding the use of local excision in rectal cancer.

Publication types

  • Practice Guideline
  • Systematic Review

MeSH terms

  • Alpha Particles
  • Antineoplastic Agents / therapeutic use
  • Chemoradiotherapy, Adjuvant
  • Consensus
  • Delphi Technique
  • Evidence-Based Practice
  • Humans
  • Magnetic Resonance Imaging
  • Neoplasm Recurrence, Local / prevention & control
  • Neoplasm Staging / methods
  • Patient Selection
  • Postoperative Complications / prevention & control
  • Proctectomy / methods
  • Proctoscopy
  • Quality of Life
  • Rectal Neoplasms / diagnostic imaging
  • Rectal Neoplasms / pathology*
  • Rectal Neoplasms / surgery*
  • Rectal Neoplasms / therapy
  • Societies, Medical
  • Standard of Care
  • Treatment Outcome
  • United States
  • Watchful Waiting

Substances

  • Antineoplastic Agents